Manufacturer addresses concerns about FIV vaccine [2]

Journal of the American Veterinary Medical Association

Volumn 222, Issue 2, 2003, Pages 149-

  Connell, Steve ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FELINE LEUKEMIA VIRUS VACCINE; VETERINARY DRUG;

ANIMAL HEALTH; ANIMAL TESTING REFINEMENT; CAT; COST BENEFIT ANALYSIS; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; SCIENTIFIC LITERATURE; VACCINATION;

ANIMALS; CATS; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; POLYMERASE CHAIN REACTION; RETROVIRIDAE PROTEINS, ONCOGENIC; VIRAL VACCINES;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; FELIS CATUS;

EID: 0037439229     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Leutenegger CM, Klein D, Hoffman-Lehman R, et al. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the Taq Man fluorogenic real time detection. J Virol Methods 1999;78:105-116.
2. Leutenegger CM. The real-time Taq Man PCR and applications in veterinary medicine. Vet Sci Tomorrow January 2001;1. Available at www.vetscite.org/cgi-bin/pw.exe/vst/tools/index.html. Accessed Dec 10, 2002.